The New York State Department of Health has approved the performance of ThyraMir testing on samples presented via cytology slides, FFPE-fixed tissue specimens, or fine needle aspirates.
Read MoreA retrospective study found that PacBio’s SMRT sequencing identified superior HLA matches, which are critical for determining successful transplant outcomes.
Read More
Over the past 3 years, the reimbursement landscape for molecular diagnostics has changed dramatically.
Read More
The test broadens expectant parents’ prenatal testing options to include a safe, noninvasive test tailored to their family’s risk for a specific genetic disease.
Read More
The Foresight carrier screen identified 45% more couples at risk for having a child with cystic fibrosis than current guideline-based testing.
Read More